IndieBio

Investor type Accelerator
Founders Arvind Gupta Bill Liao Sean O'Sullivan

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 351
Average round size
info
The average size of a deal this fund participated in
$2M
Portfolio companies 181
Rounds per year 43.88
Lead investments 6
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.47
Exits 2
Key employees Soon
Stages of investment
Seed

Areas of investment

  • Biotechnology
  • Health Care
  • Medical
  • Food and Beverage
  • Life Science
Summary

IndieBio appeared to be the VC, which was created in 2014. The venture was found in North America in United States. The leading representative office of defined VC is situated in the San Francisco.

The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the IndieBio, startups are often financed by SOSV, Velocity, Enterprise Ireland. The meaningful sponsors for the fund in investment in the same round are True Ventures, Supernode Ventures, Starlight Ventures. In the next rounds fund is usually obtained by SOSV, True Ventures, New Crop Capital.

The current fund was established by Arvind Gupta, Bill Liao.

Deals in the range of 1 - 5 millions dollars are the general things for fund. The higher amount of exits for fund were in 2019. The fund is generally included in 25-48 deals every year. Comparing to the other companies, this IndieBio performs on 28 percentage points less the average number of lead investments. The typical startup value when the investment from IndieBio is 1-5 millions dollars. The important activity for fund was in 2019. Considering the real fund results, this VC is 19 percentage points less often commits exit comparing to other organizations.

Besides, a startup needs to be aged 2-3 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Girihlet, Sun Genomics, BeeFlow. Among the most successful fund investment fields, there are Food and Beverage, Biotechnology. The fund has exact preference in a number of founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.

Read more

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Zymochem

Biotechnology
Chemical
Industrial
$4M08 Dec 2021 California, United States

Lingrove

Advanced Materials
Construction
Manufacturing
Mechanical Engineering
$4M24 Nov 2021 San Francisco, California, United States

New Culture

Food and Beverage
$25M22 Nov 2021 San Francisco, California, United States

Kyomei

Agriculture
AgTech
Biotechnology
Organic Food
Sustainability
12 Oct 2021 Oxford, Oxfordshire, United Kingdom

New Age Meats

Biotechnology
Food and Beverage
$25M27 Sep 2021 Berkeley, California, United States

Finless Foods

Biotechnology
Consumer Goods
Food and Beverage
Food Processing
16 Aug 2021 Berkeley, California, United States

Beeflow

Agriculture
Biotechnology
Natural Resources
Sustainability
$8M29 Jun 2021 Los Angeles, California, United States

QuantumCyte

Biotechnology
Life Science
Medical
23 Jun 2021 Sunnyvale, California, United States

Plantruption

Food and Beverage
Food Processing
Product Research
Seafood
21 Jun 2021 Dublin, Dublin, Ireland
News
Beeflow raises $8.3 million to save the bees AND put them to work

– Beeflow, a startup that announced the close of a $8.3m Series A round, is looking to both save the bees and help farmers be more efficient and effective at the same time.
– The financing round was led by Ospraie Ag Science, with participation from Future VenturesSteve Jurvetson, Jeff Wilke, Vectr Ventures, SOSV’s IndieBio and Grid Exponential.
– The startup uses proprietary scientific technology that essentially makes bees healthier, particularly in cold weather.
– A wealth of research led the company to understand that certain plant-based foods and molecules, when fed to the bees, can reduce the mortality rate of bees by up to 70 percent, and help them perform better in colder weather.
– You might be wondering what I mean by performance. That’s fair.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent IndieBio?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: